Androgen-induced enhancement of vascular reactivity.
D000704:Analysis of Variance; D000728:Androgens / Q000494:pharmacology*; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001808:Blood Vessels / Q000187:drug effects*; D001835:Body Weight / Q000187:drug effects; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004573:Electrolytes / Q000097:blood; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006493:Heparin / Q000494:pharmacology; D006614:Hindlimb; D007273:Injections, Intramuscular; D008297:Male; D008777:Methyltestosterone / Q000494:pharmacology; D005996:Nitroglycerin / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010477:Perfusion; D011433:Propranolol / Q000494:pharmacology; D013739:Testosterone / Q000494:pharmacology; D014439:Tyramine / Q000494:pharmacology; D014655:Vascular Resistance / Q000187:drug effects
D000728:Androgens; D004573:Electrolytes; D000804:Angiotensin II; D013739:Testosterone; D006493:Heparin; D011433:Propranolol; D005996:Nitroglycerin; D008777:Methyltestosterone; D009638:Norepinephrine; D014439:Tyramine